Form 4: Arvinas Director Leslie V. Norwalk Acquires Shares

Arvinas, Inc. reports that Director Leslie V. Norwalk acquired 15,527 shares of common stock and was granted options for 22,714 shares.

Summary

• Leslie V. Norwalk, a Director at Arvinas, Inc., acquired 15,527 shares of common stock on June 24, 2026.
• The acquisition of common stock was made at no cost.
• Additionally, Norwalk was granted stock options to purchase 22,714 shares of common stock at an exercise price of $8.05 per share.
• These stock options are set to expire on June 23, 2036.
• Both the restricted stock units (RSUs) and the stock options vest in full on the earlier of June 24, 2027, or immediately prior to the first annual meeting of stockholders after the grant date, contingent upon continued service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard executive compensation practices and continued director engagement rather than significant new financial performance indicators.

Positives

• Director Leslie V. Norwalk has increased her beneficial ownership of Arvinas, Inc. common stock.
• The acquisition of 15,527 shares and the grant of options for 22,714 shares indicate continued commitment and potential future equity upside for a key executive.
• The vesting schedule tied to continued service aligns management's interests with the company's long-term performance.

Risks

• The vesting of RSUs and stock options is contingent upon continued service, meaning departure from the company before vesting dates would result in forfeiture.
• The value of the stock options is subject to market fluctuations and the company's future stock performance.

Future Outlook

The future outlook for the acquired shares and options is tied to the continued service of Leslie V. Norwalk and the future performance of Arvinas, Inc.'s common stock. The options have a long expiration date of June 23, 2036, suggesting a long-term incentive.

Industry Context

StockSavvy.ai notes that grants of stock options and RSUs to directors are standard practice in the biotechnology and pharmaceutical sectors, aligning executive and director compensation with shareholder value and long-term company growth.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of confidence in the company's future, though it does not immediately impact share count or market capitalization.
• Employees: Standard compensation practice for directors, reinforcing alignment with company goals.
• Management: Standard equity grant, aligning director's interests with long-term company success.

Next Steps

• Leslie V. Norwalk to continue her service with Arvinas, Inc. to meet vesting requirements for RSUs and stock options.
• Monitoring of Arvinas, Inc.'s stock performance to assess the value of the granted options.

Key Dates

Keywords

Arvinas Inc, ARVN, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director, Beneficial Ownership, Equity Grant